The week in health tech, explained in plain English.Get the free newsletter →
November 12, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

KFF Reporters Tackle FDA Sunscreen Lag, Rural Dialysis Closures

KFF Health News reporters made the national media rounds last week to break down two stories that share a common thread: patients losing access to care and products that are routine elsewhere.

The first is the FDA's pace on sunscreen. According to KFF Health News, the United States still lacks many of the newer ultraviolet filters long available in Europe and Asia because federal regulators treat sunscreen ingredients as drugs requiring extensive safety review. The result is that American consumers have fewer modern options for sun protection even as skin cancer rates remain a public health concern.

The second is the closure of rural dialysis clinics in Nebraska. KFF Health News reported that shutdowns force kidney patients, who typically need treatment three times a week, to drive long distances or go without. For people with end-stage renal disease, missed sessions can be life-threatening.

Both stories underscore how policy decisions and market economics translate directly into narrower choices for patients.

More in Government

Government

Democrats Float 'Medicare for Kids' Ahead of 2026 Midterms

Democrats are floating a narrower "Medicare for Kids" proposal alongside the broader Medicare for All push as healthcare shapes the 2026 midterm debate.

Why it matters: The direction of Democratic healthcare policy could reshape coverage, reimbursement, and payer dynamics across the industry depending on 2026 election outcomes.

Government

BIO Sues to Block Medicare Peer-Country Drug Pricing Pilot

BIO has sued to block a Medicare pilot that ties certain US drug prices to peer-country benchmarks, the latest challenge to Trump's most-favored-nation pricing push.

Why it matters: The outcome will shape how far the federal government can use Medicare pilots to push US drug prices toward what other countries pay.

Government

CMS Finalizes 2.4% Home Health Pay Bump for 2027

CMS finalized a 2.4% home health payment increase for 2027 while tightening Medicare provider enrollment rules to fight fraud.

Why it matters: The rule sets 2027 reimbursement for home health agencies and raises compliance stakes as CMS cracks down on fraud.